RECENT ANALYSIS
Department Issues RFI on State Laws with Out-Of-State Economic Impacts as Trump Administration Rescinds Biden-Era Executive Order on Competition; Comments on the RFI Due Sept. 15
The Department of Justice (DOJ), in partnership with the National Economic Council, launched an initiative to examine state laws that may significantly and negatively affect the national economy or interstate commerce. The effort stems from the Trump Administration’s broader deregulatory agenda, which has emphasized reducing regulatory burdens on businesses and consumers. Building on several recent Executive Orders (EOs), DOJ highlights… (Colocho, August 18, 2025) #Costs, #Drug Pricing, #Hospitals, #Prescription Drugs, #Transparency
President Trump Issues EO to Bolster the Strategic API Reserve
Yesterday, President Trump issued an executive order (EO) entitled: “Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredient (API) Reserve.” This EO seeks to builds on President Trump’s first term EO on combatting public health emergencies and strengthening national security by ensuring essential medicines, medical countermeasures, and critical inputs are made in the United States through… (Slifer, August 14, 2025) #Prescription Drugs
Agency Hosts Listening Session on Modernizing Real-Time Claims Processing & Enhancing EDI Cybersecurity
The Centers for Medicare & Medicaid Services (CMS) convened a listening session to gather industry input on two key priorities: real-time claims processing in Medicare and Electronic Data Interchange (EDI) cybersecurity controls. These efforts are part of CMS’s strategy to strengthen Medicare’s digital infrastructure, especially in the aftermath of the 2024 cyberattack on Change Healthcare, which disrupted billing operations for… (Eisen, August 13, 2025) #Health Information Technology, #Privacy